Long-term follow-up for knee osteoarthritis patients who received FURESTEM-OA injection
Part of Bones, joints & muscles clinical trials.
This study follows people who already received a stem cell injection for knee osteoarthritis in a previous trial. The goal is to track their health and safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the K0701 study and received the FURESTEM-OA Kit injection.
- You are willing to sign a consent form to join this follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stem cell injection for knee osteoarthritis in patients who previously received a placebo. It aims to see if the treatment is safe and effective over a longer period.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new stem cell treatment (NCR100) for knee osteoarthritis. It aims to see if the injection can reduce pain and improve knee function in people with moderate knee OA.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This study tests a new way to collect how people with knee osteoarthritis feel and function after usual care (like injections, nerve-blocking procedures, or knee replacement). It may help improve future treatment decisions by using your regular follow-up reports in an app or online.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.